A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2009
11/25/2009	CN101584766A Compound schizonepeta Chinese medicinal soup used for treating urticaria
11/25/2009	CN101584744A Chinese medicinal powder used for treating urticaria
11/25/2009	CN100562525C Zymolysis process for preparing high-immunity regulation activity wolfberry polysaccharides using wolfberry wine residues
11/25/2009	CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/24/2009	US7622612 Tricyclic derivatives and their use
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009	US7622480 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622450 Flavone C-glycoside derivatives and compositions containing the derivatives
11/24/2009	US7622444 Methods for using OX-40 ligand to enhance an antigen specific immune response
11/24/2009	US7622297 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	CA2541832C Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2376870C Method for scavenging radicals with urocanic acid, derivatives and analogues
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009	WO2009140236A2 Staphylococcus aureus-specific antibody preparations
11/19/2009	WO2009140128A2 Compounds and compositions as kinase inhibitors
11/19/2009	WO2009139928A2 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009	WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009	WO2009139891A2 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009138494A2 Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors
11/19/2009	WO2009138413A1 Single domain antibodies that bind il-13
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009116524A9 Modified protein
11/19/2009	WO2009103007A3 Steroid hormone receptor modulator compounds and methods
11/19/2009	WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009	WO2009015447A3 Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders
11/19/2009	WO2008145839A8 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
11/19/2009	WO2008093166A3 Targeting macrophages through sialoadhesin
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286863 Sulfamatobenzothiophene derivatives
11/19/2009	US20090286860 Method of using adenoviral vectors to induce an immune response
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
11/19/2009	US20090286784 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/19/2009	US20090286778 Macrocyclic compounds and their use as kinase inhibitors
11/19/2009	US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/19/2009	US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009	US20090285917 Composition comprising complex crude drug extracts showing anti-allergic rhinitis, anti-atopic dermatitis and anti-asthma activity
11/19/2009	US20090285900 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285880 Dried reconstituted vesicle formation for pharmaceutical application
11/19/2009	US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009	US20090285858 Prevention of allergy in children
11/19/2009	US20090285857 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090285845 Domains And Epitopes Of Meningococcal Protein NMB1870
11/19/2009	US20090285843 Epitope sequences
11/19/2009	US20090285839 Antigen uptake receptor for candida albicans on dendritic cells
11/19/2009	US20090285831 Immunointeractive molecules
11/19/2009	US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009	US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009	US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009	US20090285789 Methods for enhancing innate and adaptive immunity and antigen immunogenicity
11/19/2009	US20090285752 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/19/2009	CA2760493A1 Staphylococcus aureus-specific antibody preparations
11/19/2009	CA2724525A1 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
11/19/2009	CA2724418A1 Long term disease modification using immunostimulatory oligonucleotides
11/19/2009	CA2724232A1 Sulfone compounds which modulate the cb2 receptor
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/18/2009	EP2119793A1 Methods for producing modified glycoproteins
11/18/2009	EP2119718A1 Macrocyclic compound
11/18/2009	EP2119712A1 Novel methylated catechin and composition containing the same
11/18/2009	EP2119445A1 Prophylactic agent for autoimmune disease
11/18/2009	EP2118142A2 Humaneered anti-factor b antibody
11/18/2009	EP2118107A1 Mercaptopurine derivatives as anticancer agents
11/18/2009	EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009	EP2118060A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
11/18/2009	EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/18/2009	EP2117567A1 Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
11/18/2009	EP2117529A2 Methods for treating diseases of altered ige regulation
11/18/2009	EP1660449B1 Aminopropanol derivatives
11/18/2009	EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
11/18/2009	EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009	EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009	CN101583608A Chromene S1P1 receptor antagonist
11/18/2009	CN101583367A Materials and methods for treating and managing angiogenesis-mediated diseases
11/18/2009	CN101583358A Use of PKC inhibitors in transplantation
11/18/2009	CN101580792A Composition used for preparing health wine and health wine
11/18/2009	CN101580755A Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris
11/18/2009	CN101580553A Preparation method of cynomorium songaricum polysaccharide
11/18/2009	CN101580551A Method for extracting polygonatum odoratum polysaccharide
11/18/2009	CN101580546A Human anti human interferon alpha antibody and application thereof

1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 1172